

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | complement activation, alternative pathway (GO:0006957) | 9.67220594 |
| 2 | drug catabolic process (GO:0042737) | 8.99797572 |
| 3 | omega-hydroxylase P450 pathway (GO:0097267) | 8.57986905 |
| 4 | regulation of protein activation cascade (GO:2000257) | 8.06204304 |
| 5 | epoxygenase P450 pathway (GO:0019373) | 7.79731159 |
| 6 | regulation of complement activation (GO:0030449) | 7.63553503 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.73409761 |
| 8 | L-phenylalanine catabolic process (GO:0006559) | 6.73409761 |
| 9 | regulation of triglyceride catabolic process (GO:0010896) | 6.45797952 |
| 10 | cellular glucuronidation (GO:0052695) | 6.17171760 |
| 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.08383861 |
| 12 | L-phenylalanine metabolic process (GO:0006558) | 6.08383861 |
| 13 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 6.07444735 |
| 14 | glucuronate metabolic process (GO:0019585) | 5.87954350 |
| 15 | uronic acid metabolic process (GO:0006063) | 5.87954350 |
| 16 | regulation of fibrinolysis (GO:0051917) | 5.73830991 |
| 17 | negative regulation of fibrinolysis (GO:0051918) | 5.72837538 |
| 18 | blood coagulation, intrinsic pathway (GO:0007597) | 5.69137665 |
| 19 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.58206016 |
| 20 | protein carboxylation (GO:0018214) | 5.58206016 |
| 21 | urea metabolic process (GO:0019627) | 5.48135613 |
| 22 | opsonization (GO:0008228) | 5.46607050 |
| 23 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 5.32619150 |
| 24 | negative regulation of protein activation cascade (GO:2000258) | 5.26294747 |
| 25 | positive regulation of chemokine secretion (GO:0090197) | 5.23176366 |
| 26 | drug metabolic process (GO:0017144) | 5.18685650 |
| 27 | nerve growth factor signaling pathway (GO:0038180) | 5.17266550 |
| 28 | aromatic amino acid family catabolic process (GO:0009074) | 5.15282788 |
| 29 | polyketide metabolic process (GO:0030638) | 5.12108765 |
| 30 | doxorubicin metabolic process (GO:0044598) | 5.12108765 |
| 31 | daunorubicin metabolic process (GO:0044597) | 5.12108765 |
| 32 | protein activation cascade (GO:0072376) | 5.09182081 |
| 33 | cytolysis (GO:0019835) | 5.00783393 |
| 34 | nitrogen cycle metabolic process (GO:0071941) | 4.98240258 |
| 35 | bile acid biosynthetic process (GO:0006699) | 4.90936878 |
| 36 | regulation of humoral immune response (GO:0002920) | 4.88624737 |
| 37 | bile acid and bile salt transport (GO:0015721) | 4.83369146 |
| 38 | fibrinolysis (GO:0042730) | 4.76520504 |
| 39 | oxidative demethylation (GO:0070989) | 4.74754524 |
| 40 | complement activation (GO:0006956) | 4.70615249 |
| 41 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.52989475 |
| 42 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.52989475 |
| 43 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.52228430 |
| 44 | complement activation, classical pathway (GO:0006958) | 4.49683125 |
| 45 | regulation of chemokine secretion (GO:0090196) | 4.48067671 |
| 46 | imidazole-containing compound metabolic process (GO:0052803) | 4.47608922 |
| 47 | bile acid metabolic process (GO:0008206) | 4.42968857 |
| 48 | glyoxylate metabolic process (GO:0046487) | 4.41802923 |
| 49 | tyrosine metabolic process (GO:0006570) | 4.41163365 |
| 50 | acute-phase response (GO:0006953) | 4.37237639 |
| 51 | negative regulation of norepinephrine secretion (GO:0010700) | 4.34729100 |
| 52 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.34518037 |
| 53 | negative regulation of hemostasis (GO:1900047) | 4.20719095 |
| 54 | negative regulation of blood coagulation (GO:0030195) | 4.20719095 |
| 55 | urea cycle (GO:0000050) | 4.16171210 |
| 56 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.15165265 |
| 57 | S-adenosylmethionine metabolic process (GO:0046500) | 4.09532339 |
| 58 | positive regulation of vasculogenesis (GO:2001214) | 4.02963155 |
| 59 | positive regulation of blood coagulation (GO:0030194) | 3.90903294 |
| 60 | positive regulation of hemostasis (GO:1900048) | 3.90903294 |
| 61 | negative regulation of coagulation (GO:0050819) | 3.88847062 |
| 62 | negative regulation of complement activation (GO:0045916) | 3.85318527 |
| 63 | negative regulation of wound healing (GO:0061045) | 3.74934858 |
| 64 | tryptophan catabolic process (GO:0006569) | 3.74725479 |
| 65 | indole-containing compound catabolic process (GO:0042436) | 3.74725479 |
| 66 | indolalkylamine catabolic process (GO:0046218) | 3.74725479 |
| 67 | positive regulation of coagulation (GO:0050820) | 3.70469517 |
| 68 | positive regulation of macrophage activation (GO:0043032) | 3.67942203 |
| 69 | intestinal cholesterol absorption (GO:0030299) | 3.66240063 |
| 70 | flavonoid metabolic process (GO:0009812) | 3.58539687 |
| 71 | rRNA methylation (GO:0031167) | 3.56863619 |
| 72 | arginine catabolic process (GO:0006527) | 3.56697434 |
| 73 | serine family amino acid catabolic process (GO:0009071) | 3.49015453 |
| 74 | negative regulation of neurotransmitter transport (GO:0051589) | 3.44844411 |
| 75 | amine catabolic process (GO:0009310) | 3.44032606 |
| 76 | cellular biogenic amine catabolic process (GO:0042402) | 3.44032606 |
| 77 | regulation of acute inflammatory response (GO:0002673) | 3.38760089 |
| 78 | triglyceride homeostasis (GO:0070328) | 3.35038488 |
| 79 | acylglycerol homeostasis (GO:0055090) | 3.35038488 |
| 80 | thrombin receptor signaling pathway (GO:0070493) | 3.31723587 |
| 81 | Rap protein signal transduction (GO:0032486) | 3.30545254 |
| 82 | arginine metabolic process (GO:0006525) | 3.28147515 |
| 83 | hormone catabolic process (GO:0042447) | 3.24479911 |
| 84 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.24292373 |
| 85 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.24292373 |
| 86 | aromatic amino acid family metabolic process (GO:0009072) | 3.23288382 |
| 87 | phenylpropanoid metabolic process (GO:0009698) | 3.22612539 |
| 88 | glycine metabolic process (GO:0006544) | 3.20596310 |
| 89 | acute inflammatory response (GO:0002526) | 3.19263796 |
| 90 | regulation of plasminogen activation (GO:0010755) | 3.18376008 |
| 91 | xenobiotic catabolic process (GO:0042178) | 3.16960577 |
| 92 | rRNA modification (GO:0000154) | 3.16960334 |
| 93 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.14346835 |
| 94 | sodium-independent organic anion transport (GO:0043252) | 3.11741802 |
| 95 | negative regulation of cholesterol transport (GO:0032375) | 3.10945955 |
| 96 | negative regulation of sterol transport (GO:0032372) | 3.10945955 |
| 97 | regulation of blood coagulation (GO:0030193) | 3.10932961 |
| 98 | regulation of hemostasis (GO:1900046) | 3.10932961 |
| 99 | coenzyme catabolic process (GO:0009109) | 3.07174391 |
| 100 | exogenous drug catabolic process (GO:0042738) | 10.2676344 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.24951410 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.09468069 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.02132168 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.73366969 |
| 5 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.25190061 |
| 6 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.15708423 |
| 7 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.07054909 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.05191580 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.00718587 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.87811836 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.69538916 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.61156870 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.27537772 |
| 14 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.10951702 |
| 15 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.00736732 |
| 16 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.81410184 |
| 17 | VDR_22108803_ChIP-Seq_LS180_Human | 1.78260556 |
| 18 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.73556074 |
| 19 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.71946225 |
| 20 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.69465814 |
| 21 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.68665673 |
| 22 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.65662514 |
| 23 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.64872554 |
| 24 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.62650517 |
| 25 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62321465 |
| 26 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.61326524 |
| 27 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.52991330 |
| 28 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.51301587 |
| 29 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.50076821 |
| 30 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.48843106 |
| 31 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.47984551 |
| 32 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.46093750 |
| 33 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.43849099 |
| 34 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.40035346 |
| 35 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.39850472 |
| 36 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.39850472 |
| 37 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.37761716 |
| 38 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.33274665 |
| 39 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.33107761 |
| 40 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.32456744 |
| 41 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.28536139 |
| 42 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.25557626 |
| 43 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.25557626 |
| 44 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.24714016 |
| 45 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.23934573 |
| 46 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.23337453 |
| 47 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.22552837 |
| 48 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.22293261 |
| 49 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.21447349 |
| 50 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.20301807 |
| 51 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.19436210 |
| 52 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17515800 |
| 53 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.16426376 |
| 54 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.16358203 |
| 55 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.15306899 |
| 56 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.13538621 |
| 57 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.12830439 |
| 58 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.11881779 |
| 59 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.11444992 |
| 60 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.11201633 |
| 61 | NFYA_21822215_ChIP-Seq_K562_Human | 1.10628990 |
| 62 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.09626352 |
| 63 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.09611043 |
| 64 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.09053697 |
| 65 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.08421460 |
| 66 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.06934297 |
| 67 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.06862157 |
| 68 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.05711336 |
| 69 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.05607599 |
| 70 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.05099100 |
| 71 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.04886483 |
| 72 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 1.04286096 |
| 73 | TCF4_23295773_ChIP-Seq_U87_Human | 1.03020757 |
| 74 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.02745340 |
| 75 | GATA2_19941826_ChIP-Seq_K562_Human | 1.02654388 |
| 76 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.02127094 |
| 77 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.02118084 |
| 78 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.99109471 |
| 79 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.98929383 |
| 80 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98605100 |
| 81 | CJUN_26792858_Chip-Seq_BT549_Human | 0.98434339 |
| 82 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.98303368 |
| 83 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.98235235 |
| 84 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.97988838 |
| 85 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97397471 |
| 86 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.97308453 |
| 87 | AR_20517297_ChIP-Seq_VCAP_Human | 0.96962228 |
| 88 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.96617193 |
| 89 | AR_25329375_ChIP-Seq_VCAP_Human | 0.96439692 |
| 90 | GATA1_19941826_ChIP-Seq_K562_Human | 0.96267632 |
| 91 | STAT3_23295773_ChIP-Seq_U87_Human | 0.96237374 |
| 92 | NFYB_21822215_ChIP-Seq_K562_Human | 0.95889562 |
| 93 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.95255837 |
| 94 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94312308 |
| 95 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.94050154 |
| 96 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.93651835 |
| 97 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.93259055 |
| 98 | P300_19829295_ChIP-Seq_ESCs_Human | 0.92969051 |
| 99 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.92360279 |
| 100 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.92090836 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.37667049 |
| 2 | MP0003252_abnormal_bile_duct | 5.84664384 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.57560040 |
| 4 | MP0005365_abnormal_bile_salt | 5.38122798 |
| 5 | MP0002138_abnormal_hepatobiliary_system | 4.60678683 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.11843370 |
| 7 | MP0003195_calcinosis | 3.76561864 |
| 8 | MP0005464_abnormal_platelet_physiology | 3.72062330 |
| 9 | MP0005670_abnormal_white_adipose | 3.50646426 |
| 10 | MP0005360_urolithiasis | 3.12477272 |
| 11 | MP0009697_abnormal_copulation | 2.90889492 |
| 12 | MP0003868_abnormal_feces_composition | 2.89129683 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.74525220 |
| 14 | MP0005187_abnormal_penis_morphology | 2.34891539 |
| 15 | MP0000569_abnormal_digit_pigmentation | 2.29255224 |
| 16 | MP0010329_abnormal_lipoprotein_level | 2.21450553 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.17371639 |
| 18 | MP0003806_abnormal_nucleotide_metabolis | 1.95870515 |
| 19 | MP0010368_abnormal_lymphatic_system | 1.90737075 |
| 20 | MP0005332_abnormal_amino_acid | 1.89966730 |
| 21 | MP0005084_abnormal_gallbladder_morpholo | 1.80789976 |
| 22 | MP0003300_gastrointestinal_ulcer | 1.71454110 |
| 23 | MP0000609_abnormal_liver_physiology | 1.61392036 |
| 24 | MP0002118_abnormal_lipid_homeostasis | 1.59974023 |
| 25 | MP0001661_extended_life_span | 1.37683846 |
| 26 | MP0002876_abnormal_thyroid_physiology | 1.33707728 |
| 27 | MP0005397_hematopoietic_system_phenotyp | 1.26751582 |
| 28 | MP0001545_abnormal_hematopoietic_system | 1.26751582 |
| 29 | MP0003724_increased_susceptibility_to | 1.19966658 |
| 30 | MP0009763_increased_sensitivity_to | 1.13715724 |
| 31 | MP0009764_decreased_sensitivity_to | 1.12401017 |
| 32 | MP0000598_abnormal_liver_morphology | 1.12019379 |
| 33 | MP0002928_abnormal_bile_duct | 1.11865252 |
| 34 | MP0005319_abnormal_enzyme/_coenzyme | 1.06311809 |
| 35 | MP0001764_abnormal_homeostasis | 1.01017851 |
| 36 | MP0008775_abnormal_heart_ventricle | 0.99734675 |
| 37 | MP0000858_altered_metastatic_potential | 0.98592287 |
| 38 | MP0004084_abnormal_cardiac_muscle | 0.92921076 |
| 39 | MP0000343_altered_response_to | 0.92240000 |
| 40 | MP0009642_abnormal_blood_homeostasis | 0.89792431 |
| 41 | MP0003828_pulmonary_edema | 0.89078828 |
| 42 | MP0000230_abnormal_systemic_arterial | 0.87798494 |
| 43 | MP0008469_abnormal_protein_level | 0.85892020 |
| 44 | MP0008004_abnormal_stomach_pH | 0.83959727 |
| 45 | MP0003656_abnormal_erythrocyte_physiolo | 0.83371139 |
| 46 | MP0001915_intracranial_hemorrhage | 0.82584371 |
| 47 | MP0003279_aneurysm | 0.79565802 |
| 48 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.79125585 |
| 49 | MP0009053_abnormal_anal_canal | 0.77956524 |
| 50 | MP0002132_abnormal_respiratory_system | 0.77306207 |
| 51 | MP0009643_abnormal_urine_homeostasis | 0.77135091 |
| 52 | MP0006276_abnormal_autonomic_nervous | 0.77002845 |
| 53 | MP0002009_preneoplasia | 0.75712229 |
| 54 | MP0005636_abnormal_mineral_homeostasis | 0.72139531 |
| 55 | MP0004215_abnormal_myocardial_fiber | 0.72059189 |
| 56 | MP0008872_abnormal_physiological_respon | 0.71782455 |
| 57 | MP0002396_abnormal_hematopoietic_system | 0.71746510 |
| 58 | MP0009765_abnormal_xenobiotic_induced | 0.69765664 |
| 59 | MP0002128_abnormal_blood_circulation | 0.69588074 |
| 60 | MP0005164_abnormal_response_to | 0.68606971 |
| 61 | MP0009384_cardiac_valve_regurgitation | 0.67784316 |
| 62 | MP0005376_homeostasis/metabolism_phenot | 0.67495362 |
| 63 | MP0005595_abnormal_vascular_smooth | 0.63938792 |
| 64 | MP0001845_abnormal_inflammatory_respons | 0.62527161 |
| 65 | MP0002148_abnormal_hypersensitivity_rea | 0.62406189 |
| 66 | MP0000465_gastrointestinal_hemorrhage | 0.61595165 |
| 67 | MP0000249_abnormal_blood_vessel | 0.60844559 |
| 68 | MP0004019_abnormal_vitamin_homeostasis | 0.60104014 |
| 69 | MP0004036_abnormal_muscle_relaxation | 0.59817268 |
| 70 | MP0001986_abnormal_taste_sensitivity | 0.58781632 |
| 71 | MP0010155_abnormal_intestine_physiology | 0.56476690 |
| 72 | MP0004130_abnormal_muscle_cell | 0.56458085 |
| 73 | MP0005083_abnormal_biliary_tract | 0.54811190 |
| 74 | MP0005395_other_phenotype | 0.54379931 |
| 75 | MP0000639_abnormal_adrenal_gland | 0.54307417 |
| 76 | MP0005535_abnormal_body_temperature | 0.54221304 |
| 77 | MP0003718_maternal_effect | 0.54093076 |
| 78 | MP0004808_abnormal_hematopoietic_stem | 0.53179249 |
| 79 | MP0003011_delayed_dark_adaptation | 0.52716595 |
| 80 | MP0003315_abnormal_perineum_morphology | 0.52586296 |
| 81 | MP0005409_darkened_coat_color | 0.52325501 |
| 82 | MP0003638_abnormal_response/metabolism_ | 0.51698553 |
| 83 | MP0005166_decreased_susceptibility_to | 0.51249744 |
| 84 | MP0001756_abnormal_urination | 0.49985136 |
| 85 | MP0004133_heterotaxia | 0.48302137 |
| 86 | MP0006138_congestive_heart_failure | 0.47957999 |
| 87 | MP0005666_abnormal_adipose_tissue | 0.47180210 |
| 88 | MP0005165_increased_susceptibility_to | 0.47120243 |
| 89 | MP0005023_abnormal_wound_healing | 0.46966768 |
| 90 | MP0003633_abnormal_nervous_system | 0.44941386 |
| 91 | MP0002136_abnormal_kidney_physiology | 0.44683684 |
| 92 | MP0001851_eye_inflammation | 0.43415291 |
| 93 | MP0005385_cardiovascular_system_phenoty | 0.42312069 |
| 94 | MP0001544_abnormal_cardiovascular_syste | 0.42312069 |
| 95 | MP0006036_abnormal_mitochondrial_physio | 0.42187670 |
| 96 | MP0003763_abnormal_thymus_physiology | 0.41954706 |
| 97 | MP0002282_abnormal_trachea_morphology | 0.41200386 |
| 98 | MP0004484_altered_response_of | 0.40676211 |
| 99 | MP0000689_abnormal_spleen_morphology | 0.39585587 |
| 100 | MP0002078_abnormal_glucose_homeostasis | 0.39488021 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement deficiency (HP:0004431) | 9.89843206 |
| 2 | Conjugated hyperbilirubinemia (HP:0002908) | 8.94586202 |
| 3 | Abnormality of complement system (HP:0005339) | 7.71014578 |
| 4 | Spontaneous abortion (HP:0005268) | 7.05881216 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.81021260 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.68165574 |
| 7 | Deep venous thrombosis (HP:0002625) | 6.49307203 |
| 8 | Abnormality of the common coagulation pathway (HP:0010990) | 5.73274434 |
| 9 | Intrahepatic cholestasis (HP:0001406) | 5.61081912 |
| 10 | Glomerulonephritis (HP:0000099) | 5.57625610 |
| 11 | Gingival bleeding (HP:0000225) | 5.53492456 |
| 12 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.47782189 |
| 13 | Hypobetalipoproteinemia (HP:0003563) | 5.35669683 |
| 14 | Joint hemorrhage (HP:0005261) | 4.95237300 |
| 15 | Systemic lupus erythematosus (HP:0002725) | 4.57661886 |
| 16 | Hyperlipoproteinemia (HP:0010980) | 4.53862312 |
| 17 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.41298977 |
| 18 | Prolonged bleeding time (HP:0003010) | 4.37553537 |
| 19 | Menorrhagia (HP:0000132) | 4.27014012 |
| 20 | Epistaxis (HP:0000421) | 4.19063205 |
| 21 | Purpura (HP:0000979) | 4.02551366 |
| 22 | Abnormality of the intrinsic pathway (HP:0010989) | 3.97434489 |
| 23 | Nephritis (HP:0000123) | 3.91608784 |
| 24 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.78724594 |
| 25 | Increased mean platelet volume (HP:0011877) | 3.75495021 |
| 26 | Fat malabsorption (HP:0002630) | 3.56385900 |
| 27 | Abnormal platelet volume (HP:0011876) | 3.45739038 |
| 28 | Abnormal platelet function (HP:0011869) | 3.31684018 |
| 29 | Impaired platelet aggregation (HP:0003540) | 3.31684018 |
| 30 | Thrombophlebitis (HP:0004418) | 3.26714113 |
| 31 | Xanthomatosis (HP:0000991) | 3.25726989 |
| 32 | Joint swelling (HP:0001386) | 3.20460560 |
| 33 | Hypolipoproteinemia (HP:0010981) | 2.96244548 |
| 34 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.93648288 |
| 35 | Generalized aminoaciduria (HP:0002909) | 2.88003474 |
| 36 | Enlarged kidneys (HP:0000105) | 2.76321476 |
| 37 | Hepatocellular carcinoma (HP:0001402) | 2.75658217 |
| 38 | Abnormality of methionine metabolism (HP:0010901) | 2.75631823 |
| 39 | Abnormal biliary tract physiology (HP:0012439) | 2.70731635 |
| 40 | Bile duct proliferation (HP:0001408) | 2.70731635 |
| 41 | Hypoalphalipoproteinemia (HP:0003233) | 2.64547225 |
| 42 | Acanthocytosis (HP:0001927) | 2.62684545 |
| 43 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.55709472 |
| 44 | Abnormal delivery (HP:0001787) | 2.53766081 |
| 45 | Poikilocytosis (HP:0004447) | 2.52842653 |
| 46 | Hyperbilirubinemia (HP:0002904) | 2.52742538 |
| 47 | Petechiae (HP:0000967) | 2.52741754 |
| 48 | Renal cortical cysts (HP:0000803) | 2.51089836 |
| 49 | Hypophosphatemic rickets (HP:0004912) | 2.47670974 |
| 50 | Pulmonary embolism (HP:0002204) | 2.41943480 |
| 51 | Abnormality of nucleobase metabolism (HP:0010932) | 2.38147243 |
| 52 | Mitral stenosis (HP:0001718) | 2.32816260 |
| 53 | Hypercholesterolemia (HP:0003124) | 2.32646222 |
| 54 | Rickets (HP:0002748) | 2.29482289 |
| 55 | Steatorrhea (HP:0002570) | 2.20387087 |
| 56 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.19309421 |
| 57 | Reduced antithrombin III activity (HP:0001976) | 2.18570787 |
| 58 | Amyloidosis (HP:0011034) | 2.17353196 |
| 59 | Abnormality of iron homeostasis (HP:0011031) | 2.15998449 |
| 60 | Increased serum ferritin (HP:0003281) | 2.13768604 |
| 61 | Potter facies (HP:0002009) | 2.12616161 |
| 62 | Facial shape deformation (HP:0011334) | 2.12616161 |
| 63 | Hemorrhage of the eye (HP:0011885) | 2.09634468 |
| 64 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.07199400 |
| 65 | Delayed CNS myelination (HP:0002188) | 2.07144461 |
| 66 | Abnormality of proline metabolism (HP:0010907) | 2.01471962 |
| 67 | Hydroxyprolinuria (HP:0003080) | 2.01471962 |
| 68 | Abnormality of the renal cortex (HP:0011035) | 2.00408635 |
| 69 | Vascular calcification (HP:0004934) | 2.00137278 |
| 70 | Osteomalacia (HP:0002749) | 1.96547479 |
| 71 | Cholelithiasis (HP:0001081) | 1.95884053 |
| 72 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.94496212 |
| 73 | Neonatal hypoglycemia (HP:0001998) | 1.94058473 |
| 74 | Hyperglycinuria (HP:0003108) | 1.93433898 |
| 75 | Spontaneous hematomas (HP:0007420) | 1.87577643 |
| 76 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.86356745 |
| 77 | Hyperammonemia (HP:0001987) | 1.82862501 |
| 78 | Abnormality of alanine metabolism (HP:0010916) | 1.82107211 |
| 79 | Hyperalaninemia (HP:0003348) | 1.82107211 |
| 80 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.82107211 |
| 81 | Dry hair (HP:0011359) | 1.81911509 |
| 82 | Hyperglycinemia (HP:0002154) | 1.78332748 |
| 83 | Conjunctival telangiectasia (HP:0000524) | 1.77188168 |
| 84 | Abnormal gallbladder morphology (HP:0012437) | 1.76302245 |
| 85 | Cardiovascular calcification (HP:0011915) | 1.75757682 |
| 86 | Abnormality of purine metabolism (HP:0004352) | 1.73715956 |
| 87 | Fair hair (HP:0002286) | 1.71662784 |
| 88 | Submucous cleft hard palate (HP:0000176) | 1.69812181 |
| 89 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.64622731 |
| 90 | Abnormality of glycine metabolism (HP:0010895) | 1.64622731 |
| 91 | Elevated alkaline phosphatase (HP:0003155) | 1.62487067 |
| 92 | Widely patent fontanelles and sutures (HP:0004492) | 1.62319867 |
| 93 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.61025912 |
| 94 | Hypothermia (HP:0002045) | 1.60661403 |
| 95 | Abnormality of serum amino acid levels (HP:0003112) | 1.59381034 |
| 96 | Metabolic acidosis (HP:0001942) | 1.59009251 |
| 97 | Increased serum pyruvate (HP:0003542) | 1.56978851 |
| 98 | Gout (HP:0001997) | 1.55801673 |
| 99 | Cerebral palsy (HP:0100021) | 1.54479579 |
| 100 | Arthropathy (HP:0003040) | 1.52264124 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 3.55384251 |
| 2 | PIK3CG | 3.41426129 |
| 3 | MAP3K13 | 3.36772564 |
| 4 | TAOK3 | 3.26819974 |
| 5 | BMPR1B | 3.22797188 |
| 6 | CLK1 | 2.57387004 |
| 7 | TEC | 2.56581887 |
| 8 | CDK6 | 2.20373047 |
| 9 | EIF2AK1 | 2.09587851 |
| 10 | WNK3 | 1.77759287 |
| 11 | MAP3K7 | 1.64687335 |
| 12 | PLK2 | 1.63806310 |
| 13 | CDK8 | 1.62505720 |
| 14 | EIF2AK3 | 1.60644602 |
| 15 | MYLK | 1.51471903 |
| 16 | BRSK2 | 1.48012554 |
| 17 | CSNK1G2 | 1.47942416 |
| 18 | FRK | 1.44586356 |
| 19 | TXK | 1.44083382 |
| 20 | CSNK1G1 | 1.43827140 |
| 21 | ADRBK2 | 1.37226454 |
| 22 | BTK | 1.36829612 |
| 23 | CDK9 | 1.36404340 |
| 24 | CAMKK2 | 1.35512386 |
| 25 | CSNK1G3 | 1.34968240 |
| 26 | PRKG2 | 1.34594529 |
| 27 | BMPR2 | 1.34398872 |
| 28 | PIK3CA | 1.29458739 |
| 29 | PNCK | 1.27924431 |
| 30 | NTRK3 | 1.27631481 |
| 31 | MAPKAPK3 | 1.26292319 |
| 32 | PRKACG | 1.25849127 |
| 33 | INSRR | 1.20877245 |
| 34 | EPHA3 | 1.20245404 |
| 35 | MAP4K2 | 1.18694970 |
| 36 | JAK1 | 1.17789098 |
| 37 | TGFBR1 | 1.17332026 |
| 38 | PRKG1 | 1.16127273 |
| 39 | MAP3K2 | 1.15241765 |
| 40 | AKT3 | 1.13595437 |
| 41 | FGFR3 | 1.10127322 |
| 42 | IKBKB | 1.08280289 |
| 43 | STK39 | 1.07560534 |
| 44 | STK3 | 1.05801678 |
| 45 | SCYL2 | 1.03989142 |
| 46 | ACVR1B | 1.00042988 |
| 47 | JAK2 | 0.98948918 |
| 48 | TBK1 | 0.96605199 |
| 49 | HIPK2 | 0.96439690 |
| 50 | MAPK11 | 0.94952023 |
| 51 | MST4 | 0.91612531 |
| 52 | BCR | 0.91589852 |
| 53 | MKNK2 | 0.90966161 |
| 54 | SYK | 0.89786180 |
| 55 | MAP3K9 | 0.84674763 |
| 56 | NEK9 | 0.84307136 |
| 57 | MAP2K1 | 0.83544440 |
| 58 | ITK | 0.83425304 |
| 59 | PRKCQ | 0.81284584 |
| 60 | BMX | 0.81126871 |
| 61 | PLK4 | 0.79171493 |
| 62 | HCK | 0.78485277 |
| 63 | RAF1 | 0.78262830 |
| 64 | ZAK | 0.74847902 |
| 65 | MAP3K12 | 0.74663572 |
| 66 | WNK4 | 0.73876653 |
| 67 | ABL2 | 0.72149897 |
| 68 | FGFR4 | 0.67215102 |
| 69 | PDK1 | 0.67011249 |
| 70 | NLK | 0.66210971 |
| 71 | CSF1R | 0.66060660 |
| 72 | IGF1R | 0.65201784 |
| 73 | PTK2B | 0.64591489 |
| 74 | PDPK1 | 0.63991332 |
| 75 | GRK5 | 0.61599676 |
| 76 | PRKAA2 | 0.61122892 |
| 77 | PRKCE | 0.59522921 |
| 78 | GRK6 | 0.59391420 |
| 79 | PHKG1 | 0.59309934 |
| 80 | PHKG2 | 0.59309934 |
| 81 | GRK1 | 0.59172687 |
| 82 | OXSR1 | 0.59078935 |
| 83 | CDK3 | 0.58595784 |
| 84 | PDGFRB | 0.55409303 |
| 85 | ADRBK1 | 0.54380046 |
| 86 | PDGFRA | 0.53994560 |
| 87 | FER | 0.52332527 |
| 88 | RIPK4 | 0.51471736 |
| 89 | IRAK1 | 0.46893785 |
| 90 | TIE1 | 0.46686341 |
| 91 | CSNK1E | 0.46085963 |
| 92 | MAPK13 | 0.45733872 |
| 93 | MAP3K1 | 0.45562693 |
| 94 | PRKACA | 0.44711973 |
| 95 | CSNK1A1L | 0.42969111 |
| 96 | TRIM28 | 0.42291841 |
| 97 | EIF2AK2 | 0.42014617 |
| 98 | PIM2 | 0.41554367 |
| 99 | LYN | 0.41197850 |
| 100 | CDK7 | 0.37338538 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.74772468 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.92156208 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.70184452 |
| 4 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.65687297 |
| 5 | Retinol metabolism_Homo sapiens_hsa00830 | 3.44749186 |
| 6 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.16969806 |
| 7 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.03816184 |
| 8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.03413433 |
| 9 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.97520498 |
| 10 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.93566280 |
| 11 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.93459595 |
| 12 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.88220693 |
| 13 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.62590643 |
| 14 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.13364510 |
| 15 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.13063937 |
| 16 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.03418839 |
| 17 | Bile secretion_Homo sapiens_hsa04976 | 2.02579381 |
| 18 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.97773296 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.97214132 |
| 20 | Prion diseases_Homo sapiens_hsa05020 | 1.96563405 |
| 21 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.81846746 |
| 22 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.79774358 |
| 23 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.78339663 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.74662092 |
| 25 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.71126549 |
| 26 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.69587182 |
| 27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.67848768 |
| 28 | ABC transporters_Homo sapiens_hsa02010 | 1.49775522 |
| 29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.46462236 |
| 30 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.45577039 |
| 31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.40418751 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.24790122 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.20227681 |
| 34 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.20105524 |
| 35 | Platelet activation_Homo sapiens_hsa04611 | 1.17404088 |
| 36 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.13149300 |
| 37 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.12975247 |
| 38 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.04262682 |
| 39 | Peroxisome_Homo sapiens_hsa04146 | 0.99600268 |
| 40 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.99110672 |
| 41 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.95359936 |
| 42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.93095622 |
| 43 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.87213913 |
| 44 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.77800001 |
| 45 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.77662275 |
| 46 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.74590319 |
| 47 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69164167 |
| 48 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.67266312 |
| 49 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.65975686 |
| 50 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.62645586 |
| 51 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.60947902 |
| 52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.57485140 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.53909998 |
| 54 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.46304093 |
| 55 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.46043117 |
| 56 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.45493057 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.44194944 |
| 58 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.43062535 |
| 59 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36379223 |
| 60 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.35631304 |
| 61 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35458259 |
| 62 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.31485063 |
| 63 | Pertussis_Homo sapiens_hsa05133 | 0.27582640 |
| 64 | Amoebiasis_Homo sapiens_hsa05146 | 0.26183926 |
| 65 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.23851579 |
| 66 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.23415971 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.22774808 |
| 68 | Carbon metabolism_Homo sapiens_hsa01200 | 0.22718784 |
| 69 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.21004213 |
| 70 | Insulin resistance_Homo sapiens_hsa04931 | 0.20718666 |
| 71 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.18998149 |
| 72 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.16292642 |
| 73 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.05923204 |
| 74 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.05667429 |
| 75 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.04668789 |
| 76 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.04608205 |
| 77 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.03293384 |
| 78 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.03193573 |
| 79 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.03021778 |
| 80 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.03011217 |
| 81 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.02485274 |
| 82 | Renin secretion_Homo sapiens_hsa04924 | 0.02376366 |
| 83 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.02069063 |
| 84 | Olfactory transduction_Homo sapiens_hsa04740 | 0.01150517 |
| 85 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1045798 |
| 86 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0989160 |
| 87 | Sulfur relay system_Homo sapiens_hsa04122 | -0.0932273 |
| 88 | Glutathione metabolism_Homo sapiens_hsa00480 | -0.0916570 |
| 89 | Long-term potentiation_Homo sapiens_hsa04720 | -0.0784885 |
| 90 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0781733 |
| 91 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | -0.0720825 |
| 92 | Steroid biosynthesis_Homo sapiens_hsa00100 | -0.0656808 |
| 93 | Long-term depression_Homo sapiens_hsa04730 | -0.0522895 |
| 94 | Chemokine signaling pathway_Homo sapiens_hsa04062 | -0.0384874 |
| 95 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0365134 |
| 96 | Salivary secretion_Homo sapiens_hsa04970 | -0.0360953 |
| 97 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | -0.0334774 |
| 98 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0194171 |
| 99 | Selenocompound metabolism_Homo sapiens_hsa00450 | -0.0109276 |
| 100 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.0043585 |

